We are live on ! Find out more
AHPI

Allied Healthcare Products

Delisted

AHPI was delisted on the 2nd of February, 2023.

12 hedge funds and large institutions have $624K invested in Allied Healthcare Products in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

9% more funds holding

Funds holding: 1112 (+1)

24% less capital invested

Capital invested by funds: $825K → $624K (-$201K)

Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

AHPI Hedge Fund Activity: Q3 2019 in Review

12 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q3 2019, worth a combined $624K — down 24% from $825K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new AHPI positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $7.67K. The largest seller was UBS Group, cutting an estimated $3.67K.

  • 12 institutional investors held Allied Healthcare Products (AHPI) as of Q3 2019, up from 11 in Q2 2019.
  • Funds reported $624K of Allied Healthcare Products stock for Q3 2019, down 24% quarter-over-quarter.
  • 3 funds opened new Allied Healthcare Products positions in Q3 2019 and 2 closed out, a net change of +1 holder.
  • The largest Allied Healthcare Products buyer in Q3 2019 was Citadel Advisors, an estimated $7.67K added.
  • The largest Allied Healthcare Products seller in Q3 2019 was UBS Group, an estimated $3.67K sold.

Based on aggregated 13F filings for Q3 2019.